Suzhou
688266.SSSuzhou Zelgen Biopharmaceuticals Co., Ltd. Price (688266.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
255,580,499
(6.4919)%Balance Sheet Summary
| Total Assest | |
| Total Liabilities | |
| Total Equity | |
| Total Investments | |
| Total Liabilities And Total Equ... | |
| Total debt |
Balance Sheet
Suzhou Zelgen Biopharmaceuticals Co., Ltd.Currency: CNY
| YEAR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Current Assets | |||||||||||||||||||
| Cash And Cash Equivalents | 17.03M | 9.88M | 128.93M | 66.92M | 1.15B | 1.14B | 797.05M | 2.11B | |||||||||||
| Short Term Investments | 54.00M | 53.00M | 82.60M | 6.00M | 449.85M | 65.26M | 248.93M | 137.02M | |||||||||||
| Net Receivables | 0.00 | 0.00 | 0.00 | 2.00 | 2.62M | 62.37M | 88.99M | 101.14M | |||||||||||
| Inventory | 165.61k | 479.90k | 2.55M | 6.43M | 23.14M | 51.91M | 98.98M | 110.85M | |||||||||||
| Other Current Assets | 9.73M | 8.27M | 15.59M | 22.48M | 44.23M | 89.79M | 57.81M | 61.68M | |||||||||||
| Total Current Assets | 80.92M | 71.64M | 229.67M | 101.82M | 1.67B | 1.41B | 1.29B | 2.52B | |||||||||||
| Non Current Assets | |||||||||||||||||||
| Property, Plant, and Equipment, Net | 35.46M | 46.81M | 56.98M | 56.67M | 91.03M | 188.91M | 247.09M | 271.21M | |||||||||||
| Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Intangible Assets | 13.15M | 12.84M | 156.43M | 135.81M | 129.51M | 116.29M | 91.03M | 69.27M | |||||||||||
| Long Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | -439,849,793.16 | -55,255,671.05 | -238,934,129.32 | 5.99M | |||||||||||
| Tax Assets | 0.00 | 0.00 | 0.00 | 0.00 | 454.20M | 78.28M | 238.93M | 0.00 | |||||||||||
| Other Non-Current Assets | 7.67M | 16.34M | 11.80M | 25.97M | 65.82M | 11.78M | 38.44M | 20.41M | |||||||||||
| Total Non-Current Assets | 56.28M | 75.99M | 225.21M | 218.44M | 300.71M | 340.01M | 376.56M | 366.87M | |||||||||||
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 1.00 | |||||||||||
| Total Assets | 137.20M
+0% |
147.63M
+8% |
454.88M
+208% |
320.27M
-30% |
1.97B
+515% |
1.75B
-11% |
1.67B
-4% |
2.89B
+73% |
|||||||||||
| Liabilities | |||||||||||||||||||
| Current Liabilities | |||||||||||||||||||
| Account Payables | 9.10M | 56.50M | 63.51M | 54.03M | 64.96M | 118.19M | 151.72M | 137.73M | |||||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 60.00M | 17.67M | 131.81M | 390.79M | 795.16M | |||||||||||
| Tax Payables | 79.39k | 330.49k | 943.59k | 17.98M | 24.66M | 25.10M | 29.02M | 20.64M | |||||||||||
| Deferred Revenue | 0.00 | 956.00k | 45.19k | 0.00 | 0.00 | 87.26M | 278.76k | 0.00 | |||||||||||
| Other Current Liabilities | 2.85M | 11.59M | 13.10M | 18.16M | 36.04M | 105.43M | 157.38M | 181.64M | |||||||||||
| Total Current Liabilities | 12.02M | 69.38M | 77.56M | 150.17M | 140.88M | 380.89M | 729.19M | 1.14B | |||||||||||
| Non Current Liabilities | |||||||||||||||||||
| Long Term Debt | 0.00 | 0.00 | 1.00 | 2.00 | 34.35M | 48.18M | 93.28M | 29.46M | |||||||||||
| Deferred Revenue Non Current | 15.74M | 5.23M | 61.94M | 66.22M | 83.66M | 48.05M | 45.04M | 11.55M | |||||||||||
| Deferred Tax Liabilities Non-Current | 0.00 | 0.00 | 29.22M | 25.30M | 19.81M | 15.77M | 13.32M | 9.58M | |||||||||||
| Other Non-Current Liabilities | 0.00 | 0.00 | 4.53M | 4.83M | 0.00 | 1.00 | 1.00 | 56.60M | |||||||||||
| Total Non-Current Liabilities | 15.74M | 5.23M | 95.69M | 96.35M | 137.82M | 111.99M | 151.64M | 107.19M | |||||||||||
| Other Liabilities | 0.00 | 0.00 | 1.00 | 0.00 | 1.00 | 1.00 | 1.00 | 2.00 | |||||||||||
| Capital Lease Obligations | 0.00 | 0.00 | 0.00 | 0.00 | 4.32M | 48.18M | 43.18M | 29.46M | |||||||||||
| Total Liabilities | 27.76M
+0% |
74.61M
+169% |
173.24M
+132% |
246.52M
+42% |
278.69M
+13% |
492.88M
+77% |
880.82M
+79% |
1.24B
+41% |
|||||||||||
| Equity | |||||||||||||||||||
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.33 | 0.85 | 0.92 | 0.31 | 0.00 | |||||||||||
| Common Stock | 32.65M | 34.28M | 40.42M | 180.00M | 240.00M | 240.00M | 240.00M | 264.71M | |||||||||||
| Retained Earnings | -210,176,272.27 | -356,644,720.33 | -796,733,735.02 | -472,328,730.33 | -791,557,981.85 | -1,242,557,151.92 | -1,700,328,964.31 | -1,978,911,708.00 | |||||||||||
| Accumulated Other Comprehensive Income Loss | 286.96M | 395.39M | 982.62M | 31.58M | 48.19M | 77.79M | 118.33M | 68.06M | |||||||||||
| Other Total Stockholders Equity | 286.96M | 395.39M | 983.40M | 294.98M | 2.12B | 2.12B | 2.22B | 3.28B | |||||||||||
| Total Stockholders Equity | 109.44M | 73.02M | 226.31M | 3.43M | 1.62B | 1.20B | 759.12M | 1.63B | |||||||||||
| Minority Interest | 0.00 | 0.00 | 55.33M | 70.32M | 73.86M | 56.76M | 28.37M | 11.98M | |||||||||||
| Total Equity | 109.44M
+0% |
73.02M
-33% |
281.64M
+286% |
73.75M
-74% |
1.69B
+2,194% |
1.25B
-26% |
787.49M
-37% |
1.64B
+109% |
|||||||||||
| Total Liabilities And Total Equity | 137.20M
+0% |
147.63M
+8% |
454.88M
+208% |
320.27M
-30% |
1.97B
+515% |
1.75B
-11% |
1.67B
-4% |
2.89B
+73% |
|||||||||||
| Additional Metrics | |||||||||||||||||||
| Total Investments | 54.00M
+0% |
53.00M
-2% |
82.60M
+56% |
6.00M
-93% |
10.00M
+67% |
10.00M
+0% |
10.00M
+0% |
143.01M
+1,330% |
|||||||||||
| Total Debt | 0.00
+0% |
0.00
+0% |
4.53M
+0% |
60.00M
+1,226% |
47.70M
-20% |
223.57M
+369% |
547.80M
+145% |
824.62M
+51% |
|||||||||||
| Net Debt | -17,025,414.00 | -9,884,526.00 | -124,407,147.00 | -6,920,221.00 | -1,102,030,562.00 | -913,064,480.00 | -249,249,373.00 | -1,223,216,129.00 | |||||||||||